Literature DB >> 24337268

Pharmaceuticals. Advocates protest the cost of a hepatitis C cure.

Jon Cohen.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24337268     DOI: 10.1126/science.342.6164.1302

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus: The Veteran Birth Cohort.

Authors:  Basile Njei; Denise Esserman; Supriya Krishnan; Michael Ohl; Janet P Tate; Ronald G Hauser; Tamar Taddei; Joseph Lim; Amy C Justice
Journal:  Med Care       Date:  2019-04       Impact factor: 2.983

2.  Response-guided therapy for hepatitis C genotype 2 and 3 in those with HIV coinfection.

Authors:  Lay Lay Win; Paul James; David K Wong
Journal:  Dig Dis Sci       Date:  2014-05-21       Impact factor: 3.199

3.  The societal cost of heroin use disorder in the United States.

Authors:  Ruixuan Jiang; Inyoung Lee; Todd A Lee; A Simon Pickard
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

4.  Screening for Hepatitis C Virus: How Universal Is Universal?

Authors:  Ravi Jhaveri
Journal:  Clin Ther       Date:  2020-07-23       Impact factor: 3.393

5.  Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study.

Authors:  Jona T Stahmeyer; Siegbert Rossol; Florian Bert; Klaus H W Böker; Harald-Robert Bruch; Christoph Eisenbach; Ralph Link; Christine John; Stefan Mauss; Renate Heyne; Eckart Schott; Heike Pfeiffer-Vornkahl; Dietrich Hüppe; Christian Krauth
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

Review 6.  Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer's disease.

Authors:  Misha Angrist; Anna Yang; Boris Kantor; Ornit Chiba-Falek
Journal:  Life Sci Soc Policy       Date:  2020-10-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.